Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3792 publications

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Journal: The Annals of pharmacotherapy
Published: December 01, 2025

A meta-analysis of efficacy and safety of anti-obesity medications in the treatment of childhood obesity

A meta-analysis of efficacy and safety of anti-obesity medications in the treatment of childhood obesity

Journal: Zhonghua yi xue za zhi
Published: November 11, 2025

Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration.

Glucagon-Like Peptide-1 Receptor Agonists and Age-Related Macular Degeneration.

Journal: JAMA ophthalmology
Published: October 23, 2025

Fenfluramine and Comparative Antiseizure Therapies in Drug-Resistant Epilepsy: A Systematic Review of Efficacy, Cardiometabolic Safety, and Clinical Outcomes.

Fenfluramine and Comparative Antiseizure Therapies in Drug-Resistant Epilepsy: A Systematic Review of Efficacy, Cardiometabolic Safety, and Clinical Outcomes.

Journal: Cureus
Published: September 09, 2025

Clinical practice guidelines for the administration of third-generation anti-seizure medications.

Clinical practice guidelines for the administration of third-generation anti-seizure medications.

Journal: Seizure
Published: September 04, 2025

Reply to Chen et al. "A Postmarketing Pharmacovigilance Study of Fenfluramine: Adverse Event Data Mining and Analysis Based on the US Food and Drug Administration Public Data Open Project (openFDA)".

Reply to Chen et al. "A Postmarketing Pharmacovigilance Study of Fenfluramine: Adverse Event Data Mining and Analysis Based on the US Food and Drug Administration Public Data Open Project (openFDA)".

Journal: Pediatric neurology
Published: August 19, 2025

Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine.

Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine.

Journal: Frontiers in pharmacology
Published: August 09, 2025

Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study.

Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study.

Journal: Epilepsia open
Published: August 07, 2025

Fenfluramine for developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS): An exploratory study.

Fenfluramine for developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS): An exploratory study.

Journal: Epilepsy research
Published: July 18, 2025

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Journal: Epilepsy & behavior : E&B
Published: July 18, 2025

Fenfluramine for late-onset epileptic spasms.

Fenfluramine for late-onset epileptic spasms.

Journal: Epileptic disorders : international epilepsy journal with videotape
Published: July 03, 2025

Efficacy of Low-Dose Fenfluramine on Adult Patients With Lennox-Gastaut Syndrome.

Efficacy of Low-Dose Fenfluramine on Adult Patients With Lennox-Gastaut Syndrome.

Journal: Cureus
Published: July 01, 2025
Showing 1-12 of 3,792

Last Updated: 01/07/2026